Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

Mar 2, 2021

284_dirs_2021-03-02_d1063e12-7227-4425-8146-ebbd5bac77f0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-02-26

Reporting Person: Zachary Jennifer (EVP, General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-26 Common Stock A 24199 $72.62 Acquired 30947.115 Direct

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 5/04/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.

F2: Holdings include shares acquired in dividend reinvestment transactions.